התמכרות לאופיואידים
הערות שוליים

↑  https://www.cdc.gov/drugoverdose/opioids/terms.html
↑  American Psychiatric Association (2013), Diagnostic and Statistical Manual of Mental Disorders (5th ed.), Arlington: American Psychiatric Publishing, pp. 540–546, ISBN 978-0890425558
↑  https://www.samhsa.gov/find-help/disorders
↑  National Institute on Drug Abuse, Prescription opioid use is a risk factor for heroin use, www.drugabuse.gov (באנגלית)
↑  Lynn R. Webster, Risk Factors for Opioid-Use Disorder and Overdose, Anesthesia & Analgesia 125, 2017-11, עמ' 1741–1748 doi: 10.1213/ANE.0000000000002496
1 2 3 4 5  American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, 2013-05-22, ISBN 0-89042-555-8. (באנגלית)
1 2 3 4 5  Luis Sordo, Gregorio Barrio, Maria J Bravo, B Iciar Indave, Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies, The BMJ 357, 2017-04-26 doi: 10.1136/bmj.j1550
↑  Bikash Sharma, Ann Bruner, Gabrielle Barnett, Marc Fishman, Opioid Use Disorders, Child and adolescent psychiatric clinics of North America 25, 2016-7, עמ' 473–487 doi: 10.1016/j.chc.2016.03.002
↑  Rebecca McDonald, John Strang, Are take‐home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria, Addiction (Abingdon, England) 111, 2016-7, עמ' 1177–1187 doi: 10.1111/add.13326
1 2  WHO | Information sheet on opioid overdose, WHO
1 2  Amin Mohamadi, Jimmy J. Chan, Jayson Lian, Casey L. Wright, Risk Factors and Pooled Rate of Prolonged Opioid Use Following Trauma or Surgery: A Systematic Review and Meta-(Regression) Analysis, JBJS 100, 2018-08-01, עמ' 1332–1340 doi: 10.2106/JBJS.17.01239
↑  Data Brief 294. Drug Overdose Deaths in the United States, 1999–2016
↑  Eric J. Nestler, Reflections on: “A General Role for Adaptations in G-Proteins and the Cyclic AMP System in Mediating the Chronic Actions of Morphine and Cocaine on Neuronal Function”, Brain research 1645, 2016-08-15, עמ' 71–74 doi: 10.1016/j.brainres.2015.12.039
1 2  Mansi Shah, Martin R. Huecker, StatPearls, Treasure Island (FL): StatPearls Publishing, 2020
1 2  Richard K. Ries, Shannon C. Miller, David A. Fiellin, Principles of Addiction Medicine, Lippincott Williams & Wilkins, 2009, ISBN 978-0-7817-7477-2. (באנגלית)
↑  Afarin Rahimi‐Movaghar, Jaleh Gholami, Laura Amato, Leila Hoseinie, Pharmacological therapies for management of opium withdrawal, The Cochrane Database of Systematic Reviews 2018, 2018-06-21 doi: 10.1002/14651858.CD007522.pub2
↑  Center for Substance Abuse Treatment, [Table, Figure 4-4: Signs and Symptoms of Opioid Intoxication and Withdrawal], www.ncbi.nlm.nih.gov, ‏2006 (באנגלית)
↑  Thomas R. Kosten, Colin N. Haile, Harrison's Principles of Internal Medicine, 19, New York, NY: McGraw-Hill Education, 2014
↑  Kevin W. Chen, Annie N. Banducci, Leila Guller, Richard J. Macatee, An Examination of Psychiatric Comorbidities as a Function of Gender and Substance Type within an Inpatient Substance Use Treatment Program, Drug and alcohol dependence 118, 2011-11-01, עמ' 92–99 doi: 10.1016/j.drugalcdep.2011.03.003
↑  WHO/UNODC/UNAIDS position paper Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention
1 2  Nora D. Volkow, George F. Koob, A. Thomas McLellan, Neurobiologic Advances from the Brain Disease Model of Addiction, The New England journal of medicine 374, 2016-01-28, עמ' 363–371 doi: 10.1056/NEJMra1511480
↑  Hyman Steven, The Neurobiology of Addiction: Implications for Voluntary Control of Behavior, American Journal of Bioethics 7, 2007, עמ' 8–11
↑  Malenka RC, Nestler EJ, Hyman SE, Chapter 15: Reinforcement and Addictive Disorders, Sydor A, Brown RY (eds.). Molecular Neuropharmacology: A Foundation for Clinical Neuroscience, (2nd ed.), New York: McGraw-Hill Medical, 2009, עמ' 364–375
↑  Eric J. Nestler, Cellular basis of memory for addiction, Dialogues in Clinical Neuroscience 15, 2013-12, עמ' 431–443
1 2  James K. Ruffle, Molecular neurobiology of addiction: what’s all the (Δ)FosB about?, The American Journal of Drug and Alcohol Abuse 40, 2014-11-01, עמ' 428–437 doi: 10.3109/00952990.2014.933840
↑  Christopher M. Olsen, Natural Rewards, Neuroplasticity, and Non-Drug Addictions, Neuropharmacology 61, 2011-12, עמ' 1109–1122 doi: 10.1016/j.neuropharm.2011.03.010
↑  Romain Bourdy, Michel Barrot, A new control center for dopaminergic systems: pulling the VTA by the tail
↑  Morphine addiction - Homo sapiens (human)
↑  Rita Z. Goldstein, Nora D. Volkow, Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications, Nature reviews. Neuroscience 12, 2011-10-20, עמ' 652–669 doi: 10.1038/nrn3119
1 2  Hada Fong-ha Ieong, Zhen Yuan, Resting-State Neuroimaging and Neuropsychological Findings in Opioid Use Disorder during Abstinence: A Review, Frontiers in Human Neuroscience 11, 2017-04-06 doi: 10.3389/fnhum.2017.00169
↑  CDC Guideline for Prescribing Opioids for Chronic Pain | Drug Overdose | CDC Injury Center, www.cdc.gov, ‏2019-08-28 (באנגלית)
↑  WHO | WHO/UNODC/UNAIDS position paper, WHO
↑  Nicholls L, Bragaw L, Ruetsch C, Opioid Dependence Treatment and Guidelines, Journal of managed care pharmacy : JMCP, ‏2010-02 (באנגלית)
↑  Nina KOUDELKOVA, Opioid substitution therapy or treatment (OST), Migration and Home Affairs - European Commission, ‏2017-03-14 (באנגלית)
↑  Julie Bruneau, Keith Ahamad, Marie-Ève Goyer, Ginette Poulin, Management of opioid use disorders: a national clinical practice guideline, CMAJ : Canadian Medical Association Journal 190, 2018-03-05, עמ' E247–E257 doi: 10.1503/cmaj.170958
1 2  National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD): Report of Results and Recommendations
↑  Jennifer S. Orman, Gillian M. Keating, Buprenorphine/Naloxone, Drugs 69, 2009-03-01, עמ' 577–607 doi: 10.2165/00003495-200969050-00006
1 2  Joseph H, Stancliff S, Langrod J, Methadone Maintenance Treatment (MMT): A Review of Historical and Clinical Issues, The Mount Sinai journal of medicine, New York, ‏2000-10 (באנגלית)
↑  Connock M, Juarez-Garcia A, Jowett S, Frew E, Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation, Health Technology Assessment 11, 2007-04-03 doi: 10.3310/hta11090
↑  TIP 63: Medications for Opioid Use Disorder | SAMHSA Publications, store.samhsa.gov (ארכיון)
↑  Christian Haasen, Uwe Verthein, Peter Degkwitz, Juergen Berger, Heroin-assisted treatment for opioid dependence: Randomised controlled trial, The British Journal of Psychiatry 191, 2007/07, עמ' 55–62 doi: 10.1192/bjp.bp.106.026112
↑  Heroin-Assisted Treatment (HAT) (English/Spanish), Drug Policy Alliance (באנגלית)
↑  J. Roy Robertson, Gillian M. Raab, Malcolm Bruce, James S. McKenzie, Addressing the efficacy of dihydrocodeine versus methadone as an alternative maintenance treatment for opiate dependence: a randomized controlled trial, Addiction 101, 2006, עמ' 1752–1759 doi: 10.1111/j.1360-0443.2006.01603.x
↑  Slow‐release oral morphine as maintenance therapy for opioid dependence
↑  Judith S Beck, Cognitive behavior therapy: basics and beyond, 2011, ISBN 978-1-60918-504-6. (באנגלית)
↑  Psychosocial interventions by general practitioners, ‏18 July 2007
↑  UpToDate, www.uptodate.com
↑  Marc A. Schuckit, Treatment of Opioid-Use Disorders, https://doi.org/10.1056/NEJMra1604339, ‏2016-07-27 (באנגלית)
↑  NA, www.na.org
↑  Steven M. Melemis, Relapse Prevention and the Five Rules of Recovery, The Yale Journal of Biology and Medicine 88, 2015-09-03, עמ' 325–332
↑  Scot Thomas, MD, 12 Step Programs for Drug Rehab & Alcohol Treatment, American Addiction Centers (באנגלית)
↑  {{{מחבר}}}, Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015, Lancet (London, England) 388, 2016-10-08, עמ' 1459–1544 doi: 10.1016/S0140-6736(16)31012-1
↑  {{{מחבר}}}, Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013, Lancet 385, 2015-01-10, עמ' 117–171 doi: 10.1016/S0140-6736(14)61682-2
↑  Hughes, Evan (2018-05-02). "The Opioid that Made a Fortune for Its Maker — and for Its Prescribers". The New York Times (באנגלית אמריקאית). ISSN 0362-4331. נבדק ב-2020-02-20.
↑  American Society of Addiction Medicine. "Opioid Addiction 2016 Facts and Figures"
↑  Health, United States, 2016: With Chartbook on Long-term Trends in Health (PDF). Hyattsville, MD.: CDC, National Center for Health Statistics. 2017. p. 4.
↑   מאות אלפי מתים בארה"ב הכניסו משבר אופיואידים ללב המרוץ לנשיאות, באתר TheMarker‏, 2 במאי 2024
↑  Digital Communications Division (DCD), 5-Point Strategy To Combat the Opioid Crisis, HHS.gov, ‏2018-05-08 (באנגלית)
↑  Addressing Problematic Opioid Use in OECD Countries - en - OCDE, www.oecd.org
1 2  השימוש המוגבר במשככי כאבים נרקוטיים בישראל: תחילתה של מגפה?, באתר מרכז טאוב
↑  דוח פנימי על השימוש אופיואידים: "בעיה בריאותית וציבורית רחבה בישראל", באתר שומרים, ‏27 בספטמבר 2023
↑  דניאל דולב, שומרים, ‏המלחמה של משרד הבריאות בהתמכרות לאופיואידים, באתר ‏מאקו‏, 27 בספטמבר 2023
הבהרה: המידע בוויקיפדיה נועד להעשרה בלבד ואינו מהווה ייעוץ רפואי.